Loading clinical trials...
Loading clinical trials...
An Open-Label, Single Ascending Dose Study To Evaluate The Pharmacokinetic Profile, Safety and Tolerability of Orally Administered LYC-30937 in Subjects With Active Ulcerative Colitis
Conditions
Interventions
LYC-30937
Locations
2
Hungary
DRC Ltd.
Balatonfüred, Hungary
PRA Magyarorszag Kft
Budapest, Hungary
Start Date
March 1, 2016
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
December 14, 2016
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Lycera Corp.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions